Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

13G Filing: Partner Fund Management and Aerie Pharmaceuticals Inc (AERI)

Published on July 18, 2017 at 1:17 pm by Insider Monkey Staff in Hedge Funds

Page 11 of 13

Page 11 of 13 – SEC Filing

CUSIP No. 00771V108

13G

Page
11 of 13 Pages

C.

Brian D. Grossman

(a)

Grossman may be deemed to beneficially own 2,242,091 shares of Common Stock.

(b)

The number of shares Grossman may be deemed to beneficially own constitutes approximately 6.3% of
the Common Stock outstanding.

(c)

Number of shares as to which such person has:

(i)

sole power to vote or to direct the vote: 0

(ii)

shared power to vote or to direct the vote: 2,242,091

(iii)

sole power to dispose or to direct the disposition of: 0

(iv)

shared power to dispose or to direct the disposition of: 2,242,091

D.

Christopher M. James

(a)

James may be deemed to beneficially own 2,242,091 shares of Common Stock.

(b)

The number of shares James may be deemed to beneficially own constitutes approximately 6.3% of the
Common Stock outstanding.

(c)

Number of shares as to which such person has:

(i)

sole power to vote or to direct the vote: 0

(ii)

shared power to vote or to direct the vote: 2,242,091

(iii)

sole power to dispose or to direct the disposition of: 0

(iv)

shared power to dispose or to direct the disposition of: 2,242,091

Item 5

Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than 5 percent of the class of securities, check the following ¨.

Item 6

Ownership of More than Five Percent on Behalf of Another
Person

Not Applicable

Item 7

Identification and Classification of the Subsidiary
which Acquired the Security Being Reported on by the Parent Holding Company

See Item 2 above

Item 8

Identification and Classification of Members of the
Group

Not Applicable

Follow Aerie Pharmaceuticals Inc (NASDAQ:AERI)

Follow Aerie Pharmaceuticals Inc (NASDAQ:AERI)

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

Page 11 of 13

NASDAQ:AERI SEC 13G Filing Partner Fund Management Aerie Pharmaceuticals Inc (AERI)